• BIOSOLVE II and BIOSOLVE III Trials interview with Dr. Michael Haude

    Dr. Waksman interviews Dr. Michael Haude on the Short and midterm safety, clinical performance and multi modality imaging results of the drug-eluting absorbable metal scaffold: combined data of the BIOSOLVE-II and BIOSOLVE-III trials

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details